文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹自身免疫性与大疱性皮肤病

N6-甲基腺苷RNA甲基化在皮肤病中的全景

The landscape of N 6-methyladenosine RNA methylation in skin diseases.
PubMed 文献 · Br J Dermatol · 2025-01-01

本综述系统梳理了m6A RNA甲基化在非肿瘤性皮肤病中的调控作用与治疗意义,涉及伤口愈合、瘢痕与瘢痕疙瘩、皮肤衰老、银屑病、系统性红斑狼疮、痤疮、玫瑰痤疮、慢性光化性皮炎和硬皮病。文章指出m6A修饰影响炎症、免疫反应和细胞衰老等关键生物学过程,靶向m6A有望为这些皮肤病提供新的诊断生物标志物和治疗策略。

要点

  • m6A修饰通过影响RNA稳定性、剪接、翻译、出核和降解调控基因表达。
  • m6A修饰参与炎症、免疫反应和细胞衰老等皮肤关键生物学过程。
  • 靶向m6A可能为银屑病、伤口愈合等非肿瘤性皮肤病提供新诊疗策略。

核心结论

  • m6A修饰在多种非肿瘤性皮肤病的发病和进展中发挥关键作用,靶向m6A有望开发新型诊断生物标志物和治疗策略。

研究设计与样本

  • 综述系统梳理了m6A RNA甲基化在非肿瘤性皮肤病中的调控作用与治疗意义。
  • 文章由中国的整形与美容团队完成,通过研究现有文献总结m6A对相关皮肤病进程的影响。

主要发现

  • m6A修饰影响炎症、免疫反应和细胞衰老等皮肤关键生物学过程。
  • m6A水平变化可影响皮肤细胞的生长与修复,在银屑病和伤口愈合等过程中具有重要意义。

临床怎么用

  • 靶向m6A可能为银屑病、伤口愈合等非肿瘤性皮肤病提供新的治疗方向。
  • 深入理解m6A调控机制有望开发诊断生物标志物,改善患者预后与生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Skin diseases encompass a diverse range of conditions with significant psychological and physiological impacts. N6-methyladenosine (m6A) RNA methylation is a key epitranscriptomic modification that regulates gene expression by influencing RNA stability, splicing, translation, export and degradation. Recent studies have highlighted the crucial role of m6A modification in the pathogenesis and progression of various skin diseases. m6A modification affects critical biologic processes of the skin, such as inflammation, immune response and cellular ageing. This review systematically explores the landscape of m6A modification in nontumour skin diseases, elucidating its regulatory roles and therapeutic implications, including wound healing, scar and keloid, skin ageing, psoriasis, systemic lupus erythematosus, acne vulgaris, rosacea, chronic actinic dermatitis and scleroderma. The intricate mechanisms of m6A modification can lead to the development of novel diagnostic biomarkers and therapeutic strategies, ultimately improving patient outcomes. Skin conditions, such as psoriasis and acne, affect millions of people worldwide. They can cause physical and emotional distress. This research was carried out by a plastics and cosmetic team in China. It explored how a specific modification in RNA, called ‘m6A’, can influence skin conditions. m6A is a chemical change to RNA that can affect how genes are turned on or off in our cells. We aimed to understand how m6A impacts on skin conditions that are not cancerous. This included wound healing, psoriasis and lupus. We studied existing research to learn how m6A affects the processes that contribute to these conditions. These processes include inflammation (swelling) and immune responses. We found that changes in m6A levels can affect how skin cells grow and repair themselves. This is important in conditions like psoriasis and wound healing. Our findings suggest that targeting m6A could lead to new treatments for these skin conditions. By better understanding how m6A works, we hope to develop treatments that improve patient outcomes, reducing symptoms and improving the quality of life of people with these conditions. This research highlights the potential of m6A as a target for future drug development, offering hope for more effective treatments for people living with skin conditions.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhang Q, Liu G, Jing L, et al. The landscape of N 6-methyladenosine RNA methylation in skin diseases. Br J Dermatol. 2025. PMID: 40059697. doi:10.1093/bjd/ljaf087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。